Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press48010.17650/1994-4098-2016-12-1-73-78GYNECOLOGY. ORIGINAL ISSUESГИНЕКОЛОГИЯ. ОРИГИНАЛЬНАЯ СТАТЬЯThe role of tumor inflammatory component of the tumor microenvironment of the endometrioid adenocarcinoma of the corpus uteri in different disease outcomesРоль воспалительного компонента опухолевого микроокружения эндометриоидной аденокарциномы тела матки при различных исходах заболеванияZinovkinD. A.ЗиновкинД. А.
Russian Federation
zinych007@yandex.ruRepublican Research Center for Radiation Medicine and Human EcologyГУ «Республиканский научно-практический центр радиационной медицины и экологии человека»290 Il’icha St., Gomel’, 246040, Republic of BelarusРеспублика Беларусь, 246040, Гомель, ул. Ильича, 2900606201612173780606201606062016https://ojrs.abvpress.ru/ojrs/article/view/480

This article presents data on the role of tumor associated T cells, B cells, natural killer cells, macrophages and dendritic cells in the prognostic value of the endometrioid adenocarcinoma. Furthermore, there was determining of its role in the early (up to 3 years) progression of the disease.

Представлены данные о прогностической значимости опухоль-ассоциированных Т-лимфоцитов, В-лимфоцитов, естественных киллеров, макрофагов и дендритных клеток в отношении эндометриоидной аденокарциномы. Также определена их роль в ранней (до 3 лет) прогрессии данного заболевания.

tumor microenvironmentprognosisendometrioid adenocarcinomaопухолевое микроокружениепрогнозэндометриоидная аденокарцинома1. Shurin M.R., Umansky V., Malyguine A. The tumor immunoenvironment. Ed. by M.R. Shurin. New York: Springer, 2013. Pp. 19–125.Shurin M.R., Umansky V., Malyguine A. The tumor immunoenvironment. Ed. by M.R. Shurin. New York: Springer, 2013. Pp. 19–125.2. Жарков Н.В., Нуртазин С.Т., Жаркова И.М. Особенности морфологии и распределения опухоль-ассоциированных макрофагов в колоректальных карциномах. Вестник Казахского национального университета им. аль-Фараби. Серия Биологическая 2009; 42(3):72–6. [Zharkov M.R., Nurtazin S.T., Zharkova I.M. The morphology and distribution of tumor associated macrophages in colorectal carcinomas. Vestnik Kazakhskogo natsional’nogo universiteta im. al’-Farabi. Seriya Biologicheskaya = Bulletin of al-Farabi Kazakhstan National University. Biological Series 2009;42(3):72–6. (In Russ.)].Жарков Н.В., Нуртазин С.Т., Жаркова И.М. Особенности морфологии и распределения опухоль-ассоциированных макрофагов в колоректальных карциномах. Вестник Казахского национального университета им. аль-Фараби. Серия Биологическая 2009; 42(3):72–6. [Zharkov M.R., Nurtazin S.T., Zharkova I.M. The morphology and distribution of tumor associated macrophages in colorectal carcinomas. Vestnik Kazakhskogo natsional’nogo universiteta im. al’-Farabi. Seriya Biologicheskaya = Bulletin of al-Farabi Kazakhstan National University. Biological Series 2009;42(3):72–6. (In Russ.)].3. Damjanov I., Fan F. Cancer grading manual. Ed. by I. Damjanov. New York: Springer, 2013.Damjanov I., Fan F. Cancer grading manual. Ed. by I. Damjanov. New York: Springer, 2013.4. World Health Organization classification of tumors. Pathology and genetics of tumours of the breast and female genital organs. Lyon, 2000.World Health Organization classification of tumors. Pathology and genetics of tumours of the breast and female genital organs. Lyon, 2000.5. Реброва О.Ю. Статистический анализ медицинских данных. Применение прикладных программ Statistica. М.: Медиасфера, 2002. [Rebrova O.Yu. Statistical analysis of medical data. The use of applied programs Statistica. Moscow: Mediasfera, 2001. (In Russ.)].Реброва О.Ю. Статистический анализ медицинских данных. Применение прикладных программ Statistica. М.: Медиасфера, 2002. [Rebrova O.Yu. Statistical analysis of medical data. The use of applied programs Statistica. Moscow: Mediasfera, 2001. (In Russ.)].6. Jochems C., Schlom J. Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Exp Biol Med (Maywood) 2011;236(5):567–79.Jochems C., Schlom J. Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Exp Biol Med (Maywood) 2011;236(5):567–79.7. Čermáková P., Melichar B., Tomšová M. et al. Prognostic significance of CD3+ tumorinfiltrating lymphocytes in patients with endometrial carcinoma. Anticancer Res 2014;34(10):5555–61.Čermáková P., Melichar B., Tomšová M. et al. Prognostic significance of CD3+ tumorinfiltrating lymphocytes in patients with endometrial carcinoma. Anticancer Res 2014;34(10):5555–61.8. Ino K., Yamamoto E., Shibata K. et al. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival. Clin Cancer Res 2008;14(8): 2310–7.Ino K., Yamamoto E., Shibata K. et al. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival. Clin Cancer Res 2008;14(8): 2310–7.9. Klink M. Cancer immunoediting: elimination, equilibrium, and immune escape in solid tumors. Ed. by M. Klink. New York: Springer, 2013.Klink M. Cancer immunoediting: elimination, equilibrium, and immune escape in solid tumors. Ed. by M. Klink. New York: Springer, 2013.10. Modugno F., Ness R.B., Chen C., Weiss N.S. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 2005;14(12): 2840–7.Modugno F., Ness R.B., Chen C., Weiss N.S. Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 2005;14(12): 2840–7.11. Aviary C., LaRue H., Hovington H. et al. High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer. Hum Pathol 2013;44(8):1630–7.Aviary C., LaRue H., Hovington H. et al. High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer. Hum Pathol 2013;44(8):1630–7.